161 related articles for article (PubMed ID: 25879734)
1. The correlation between serum HBsAg levels and viral loads depends upon wild-type and mutated HBV sequences rather than the HBeAg/anti-HBe status.
Liu MH; Chen QY; Harrison TJ; Li GJ; Li H; Wang XY; Ju Y; Yang JY; Fang ZL
J Med Virol; 2015 Aug; 87(8):1351-60. PubMed ID: 25879734
[TBL] [Abstract][Full Text] [Related]
2. Chronic hepatitis B in pregnant women: is hepatitis B surface antigen quantification useful for viral load prediction?
Fujiko M; Chalid MT; Turyadi ; Ie SI; Maghfira ; Syafri ; Wahyuni R; Roni M; Patellongi I; Massi MN; Muljono DH
Int J Infect Dis; 2015 Dec; 41():83-9. PubMed ID: 26571304
[TBL] [Abstract][Full Text] [Related]
3. Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels.
Pollicino T; Amaddeo G; Restuccia A; Raffa G; Alibrandi A; Cutroneo G; Favaloro A; Maimone S; Squadrito G; Raimondo G
Hepatology; 2012 Aug; 56(2):434-43. PubMed ID: 22271491
[TBL] [Abstract][Full Text] [Related]
4. Correlation between the promoter basal core and precore mutations and HBsAg quantification in French blood donors infected with hepatitis B virus.
Pivert A; Servant-Delmas A; Lunel-Fabiani F; Le Guillou-Guillemette H; Laperche S; Ducancelle A
J Med Virol; 2015 Mar; 87(3):529-35. PubMed ID: 25170961
[TBL] [Abstract][Full Text] [Related]
5. [Correlation between serum HBV DNA level and HBsAg titer in HBeAg-positive pregnant women and impact of genomic variability of hepatitis B virus pre S/S regions on their correlations].
Zhang X; Yan L; Lu Y; Wei KP; Liu ZX; Xiao YW; Ding F; Zhuang H; Li J
Zhonghua Gan Zang Bing Za Zhi; 2018 Aug; 26(8):579-584. PubMed ID: 30317788
[No Abstract] [Full Text] [Related]
6. Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers.
Thompson AJ; Nguyen T; Iser D; Ayres A; Jackson K; Littlejohn M; Slavin J; Bowden S; Gane EJ; Abbott W; Lau GK; Lewin SR; Visvanathan K; Desmond PV; Locarnini SA
Hepatology; 2010 Jun; 51(6):1933-44. PubMed ID: 20512987
[TBL] [Abstract][Full Text] [Related]
7. Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis B.
Bayliss J; Yuen L; Rosenberg G; Wong D; Littlejohn M; Jackson K; Gaggar A; Kitrinos KM; Subramanian GM; Marcellin P; Buti M; Janssen HLA; Gane E; Sozzi V; Colledge D; Hammond R; Edwards R; Locarnini S; Thompson A; Revill PA
Gut; 2017 Nov; 66(11):2013-2023. PubMed ID: 27534671
[TBL] [Abstract][Full Text] [Related]
8. The association of HBV core promoter double mutations (A1762T and G1764A) with viral load differs between HBeAg positive and anti-HBe positive individuals: a longitudinal analysis.
Fang ZL; Sabin CA; Dong BQ; Wei SC; Chen QY; Fang KX; Yang JY; Wang XY; Harrison TJ
J Hepatol; 2009 Feb; 50(2):273-80. PubMed ID: 19070921
[TBL] [Abstract][Full Text] [Related]
9. Mutations in reverse transcriptase region of HBV affect Hepatitis B surface antigen titers and its correlation with HBV DNA.
Shen H; Chen C; Ye C; Zhang H; Hang S; Chen M; Zhu Z; Xue Y; Liu L
J Infect Dev Ctries; 2019 Nov; 13(11):1062-1067. PubMed ID: 32087080
[TBL] [Abstract][Full Text] [Related]
10. Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads.
Tseng TC; Liu CJ; Yang HC; Su TH; Wang CC; Chen CL; Hsu CA; Kuo SF; Liu CH; Chen PJ; Chen DS; Kao JH
Hepatology; 2013 Feb; 57(2):441-50. PubMed ID: 22941922
[TBL] [Abstract][Full Text] [Related]
11. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A
Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
[TBL] [Abstract][Full Text] [Related]
12. Impact of HBV genotype and mutations on HBV DNA and qHBsAg levels in patients with HBeAg-negative chronic HBV infection.
Kuhnhenn L; Jiang B; Kubesch A; Vermehren J; Knop V; Susser S; Dietz J; Carra G; Finkelmeier F; Grammatikos G; Zeuzem S; Sarrazin C; Hildt E; Peiffer KH
Aliment Pharmacol Ther; 2018 Jun; 47(11):1523-1535. PubMed ID: 29637585
[TBL] [Abstract][Full Text] [Related]
13. Serum Hepatitis B Virus DNA, RNA, and HBsAg: Which Correlated Better with Intrahepatic Covalently Closed Circular DNA before and after Nucleos(t)ide Analogue Treatment?
Gao Y; Li Y; Meng Q; Zhang Z; Zhao P; Shang Q; Li Y; Su M; Li T; Liu X; Zhuang H
J Clin Microbiol; 2017 Oct; 55(10):2972-2982. PubMed ID: 28747369
[TBL] [Abstract][Full Text] [Related]
14. Mutations of pre-core and basal core promoter before and after hepatitis B e antigen seroconversion.
Kamijo N; Matsumoto A; Umemura T; Shibata S; Ichikawa Y; Kimura T; Komatsu M; Tanaka E
World J Gastroenterol; 2015 Jan; 21(2):541-8. PubMed ID: 25593470
[TBL] [Abstract][Full Text] [Related]
15. Correlation between hepatitis B surface antigen titers and HBV DNA levels.
Alghamdi A; Aref N; El-Hazmi M; Al-Hamoudi W; Alswat K; Helmy A; Sanai FM; Abdo AA
Saudi J Gastroenterol; 2013; 19(6):252-7. PubMed ID: 24195978
[TBL] [Abstract][Full Text] [Related]
16. Correlations Among Serum Hepatitis B Surface Antigen and Hepatitis B e Antigen Titers and Viral Load in Chinese Patients with Chronic Hepatitis B.
He P; Zhan JJ; Hu TT; Hu Y; Liu Y; Yang YN; Zhang Y; Xu BG; Zhong Q; Liu WW
Clin Lab; 2015; 61(5-6):505-12. PubMed ID: 26118183
[TBL] [Abstract][Full Text] [Related]
17. Effects of amino acid substitutions in hepatitis B virus surface protein on virion secretion, antigenicity, HBsAg and viral DNA.
Xiang KH; Michailidis E; Ding H; Peng YQ; Su MZ; Li Y; Liu XE; Dao Thi VL; Wu XF; Schneider WM; Rice CM; Zhuang H; Li T
J Hepatol; 2017 Feb; 66(2):288-296. PubMed ID: 27650283
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconverters.
Tseng TC; Liu CJ; Yang WT; Chen CL; Yang HC; Su TH; Wang CC; Kuo SF; Liu CH; Chen PJ; Chen DS; Kao JH
J Gastroenterol Hepatol; 2014 Jun; 29(6):1242-9. PubMed ID: 24384028
[TBL] [Abstract][Full Text] [Related]
19. Long-term presence of HBV in the sera of chronic hepatitis B patients with HBsAg seroclearance.
Arase Y; Suzuki F; Suzuki Y; Saitoh S; Kobayashi M; Akuta N; Someya T; Hosaka T; Sezaki H; Sato J; Kobayashi M; Ikeda K; Kumada H
Intervirology; 2007; 50(3):161-5. PubMed ID: 17259734
[TBL] [Abstract][Full Text] [Related]
20. Low pretreatment serum HBsAg level and viral mutations as predictors of response to PEG-interferon alpha-2b therapy in chronic hepatitis B.
Tangkijvanich P; Komolmit P; Mahachai V; Sa-nguanmoo P; Theamboonlers A; Poovorawan Y
J Clin Virol; 2009 Oct; 46(2):117-23. PubMed ID: 19651540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
